Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SALTVAPE Study
NCT04231539Completed
- Sponsor
- Roswell Park Comprehensive Cancer Center
- Start
- Feb 2020
- Primary completion
- Jul 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of nicotine in nicotine dependence (4 arms), sponsored by Roswell Park Comprehensive Cancer Center. Primary endpoints: Maximum Concentration of Nicotine in Plasma, Area Under the Concentration-time Curve and 1 more. Started Feb 2020; status: completed.
02
Drugs
nicotine
03
Conditions
nicotine dependence
Beyond the preview
Go deeper on NCT04231539.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04231539.